CONTRAFECT Corp 4 SEC Filings

Filed On	Filing
16 Feb 2023	Form 4: Messinger Michael, Chief Financial Officer Granted 25,000 Options (Right to Buy) ($126K)
18 May 2022	Form 4: Barlow Jane F, Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Sucoff Cary, Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Otto Michael J., Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Low David N., Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Gilman Steven C, Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Barer Sol J, Director Granted 42,000 Options (Right to Buy) ($141K)
18 May 2022	Form 4: Aklog Lishan, Director Granted 42,000 Options (Right to Buy) ($141K)
17 Feb 2022	Form 4: Pomerantz Roger, Director Granted 500,000 Options (Right to Buy) ($1.67M)
17 Feb 2022	Form 4: Messinger Michael, Chief Financial Officer Granted 165,000 Options (Right to Buy) ($549K)
17 Feb 2022	Form 4: Cassino Cara M, Chief Medical Officer Granted 160,000 Options (Right to Buy) ($533K)
17 Feb 2022	Form 4: Bogdanos Natalie, General Counsel Granted 125,000 Options (Right to Buy) ($416K)
21 May 2021	Form 4: Sucoff Cary, Director Granted 25,000 Options (Right to Buy)
20 May 2021	Form 4: Otto Michael J., Director Granted 25,000 Options (Right to Buy)
20 May 2021	Form 4: Low David N., Director Granted 25,000 Options (Right to Buy)
20 May 2021	Form 4: Gilman Steven C, Director Granted 25,000 Options (Right to Buy)
20 May 2021	Form 4: Barer Sol J, Director Granted 25,000 Options (Right to Buy)
20 May 2021	Form 4: Aklog Lishan, Director Granted 25,000 Options (Right to Buy)
14 Apr 2021	Form 4: Messinger Michael, Chief Financial Officer Granted 80,000 Options (Right to Buy)
13 Apr 2021	Form 4: Cassino Cara M, Chief Medical Officer Granted 170,000 Options (Right to Buy)

Comments